Dylan V. Miller and Monica P. Revelo. Diagnostic Pathology: Cardiovascular, 3rd Edition Luigi Mansi Book Review 01 June 2023 Pages: 2571 - 2571
European guidelines update on PSMA PET/CT for prostate cancer staging—snap back to reality Fabrizia GelardiAlberto BrigantiArturo Chiti Editorial 01 June 2023 Pages: 2572 - 2575
The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe—the nuclear medicine perspective Roberto C. Delgado BoltonFrancesco GiammarileWolfgang Wadsak Editorial 10 May 2023 Pages: 2576 - 2581
Superfluous, controversial and luxury issues in nuclear medicine Ozgul EkmekciogluSamantha Y A TerryFred Verzijlbergen Editorial 24 April 2023 Pages: 2582 - 2587
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer Roberto C. Delgado BoltonAdriana K. Calapaquí TeránFrancesco Giammarile Editorial 24 March 2023 Pages: 2588 - 2590
Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models Wenyu SongWeijun WeiWeibo Cai Editorial 16 May 2023 Pages: 2591 - 2594
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry Pablo Mínguez GabiñaKatarina Sjögreen GleisnerJonathan Gear Editorial 02 May 2023 Pages: 2595 - 2604
Present and future of target therapies and theranostics: Refining traditions and exploring new frontiers Barbara HertzBennett S. Greenspan Letter to the Editor 01 April 2023 Pages: 2605 - 2605
PET imaging of PARP expression using 68Ga-labelled inhibitors Xiangwei WangWei LiuShaoli Song Original Article Open access 05 May 2023 Pages: 2606 - 2620
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition Dirk ZboralskiFrank OsterkampMinh Nguyen Original Article Open access 22 April 2023 Pages: 2621 - 2635
Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy Yu LiuHaocheng TangZhibo Liu Original Article 27 April 2023 Pages: 2636 - 2646
Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis Y. A. A. BacourM. P. van KantenY. M. Smulders Original Article Open access 28 April 2023 Pages: 2647 - 2655
Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging Michelle C. WilliamsBryan P. BednarskiPiotr J. Slomka Original Article Open access 17 April 2023 Pages: 2656 - 2668
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease Charles D. ChenAustin McCulloughfor the DIAN-TU Study Team Original Article 05 April 2023 Pages: 2669 - 2682
Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma Jiajin LiBeiwen NiYumei Chen Original Article 11 April 2023 Pages: 2683 - 2691
Radioligand therapies in cancer: mapping the educational landscape in Europe Valentina BuganiLuca BattistelliIgnasi Carrió Original Article Open access 14 April 2023 Pages: 2692 - 2698
The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria Christos SachpekidisVivienn WeruAntonia Dimitrakopoulou-Strauss Original Article Open access 26 April 2023 Pages: 2699 - 2714
Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma Narjess AyatiZahra Jamshidi-AraghiMohsen Beheshti Original Article Open access 04 May 2023 Pages: 2715 - 2726
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study Jacques DarcourtDavid ChardinAntoine Verger Original Article 22 April 2023 Pages: 2727 - 2735
Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography Milou E. NoltesMaximilian BaderSchelto Kruijff Original Article Open access 11 April 2023 Pages: 2736 - 2750
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in \([^{18}\)F]FDG PET/CT Pavel NikulinSebastian ZschaeckJörg van den Hoff Original Article Open access 20 April 2023 Pages: 2751 - 2766
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer Luca GiovanellaLisa MilanRainer Görges Original Article Open access 01 May 2023 Pages: 2767 - 2774
Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients Jiayue LiuXiaoyi GuoZhi Yang Original Article 24 April 2023 Pages: 2775 - 2786
Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes Mingzhu LiangLizhu WangDan Li Original Article 05 May 2023 Pages: 2787 - 2801
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection Shujing WangChangsong QiHua Zhu Original Article 26 April 2023 Pages: 2802 - 2817
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors Paola MapelliCarolina BezziMaria Picchio Original Article 03 April 2023 Pages: 2818 - 2829
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) Clemens KratochwilWolfgang P. FendlerKen Hermann Guidelines Open access 29 May 2023 Pages: 2830 - 2845
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression Xuejun WenPengfei XuXiaoyuan Chen Original Article 25 April 2023 Pages: 2846 - 2860
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients Esther M. K. WitGijs H. KleinJanHenk G. van der Poel Original Article 10 April 2023 Pages: 2861 - 2871
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand Yvonne H. W. DerksMelline G. M. SchilhamSusanne Lütje Original Article Open access 15 April 2023 Pages: 2872 - 2884
A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer Yun XiLili SunWeiwei Feng Original Article 24 April 2023 Pages: 2885 - 2898
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer Florian RosarFadi KhreishSamer Ezziddin Original Article Open access 06 May 2023 Pages: 2899 - 2909
[68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma Wei GuoYuhang ChenHaojun Chen Image of the Month 06 March 2023 Pages: 2910 - 2911
PET/CT scan without sedation: how to use total-body PET/CT to salvage child’s involuntary movement? Yongjiang LiJuan WangYingying Hu Image of the Month 28 March 2023 Pages: 2912 - 2913
[68 Ga]Ga-DOTA-FAPI-04: Focus the lesion in [18F]F-FDG hidden by metformin Qixin WangYan ZhuYue Chen Image of the Month 01 April 2023 Pages: 2914 - 2915
[18F]-FDG PET/CT is useful for early detection of Stewart-Treves syndrome, in patients with chronic lymphedema Ryota IchikawaKota YokoyamaUkihide Tateishi Image of the Month 14 April 2023 Pages: 2916 - 2917
Identification of isolated hepatic sarcoidosis with [18F]FDG and [68 Ga]Ga-FAPI PET/CT Yizhen PangPeipei WangHaojun Chen Image of the Month 20 April 2023 Pages: 2918 - 2919
